Treatment modalities for poor ovarian responders.
作者信息
Di Guardo Federica, Pluchino Nicola, Drakopoulos Panagiotis
机构信息
Department of General Surgery and Medical Surgical Specialties, Gynecology and Obstetrics Section, University of Catania, Via Santa Sofia 78, 95125 Catania, Italy.
Centre for Reproductive Medicine, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium.
出版信息
Ther Adv Reprod Health. 2023 Jan 24;17:26334941221147464. doi: 10.1177/26334941221147464. eCollection 2023 Jan-Dec.
Abstract
摘要
相似文献
1
Treatment modalities for poor ovarian responders.卵巢低反应者的治疗方式。
Ther Adv Reprod Health. 2023 Jan 24;17:26334941221147464. doi: 10.1177/26334941221147464. eCollection 2023 Jan-Dec.
2
Comparative study on risk for birth defects among infants after in vitro fertilization and intracytoplasmic sperm injection.体外受精与卵胞浆内单精子注射后婴儿出生缺陷风险的比较研究。
Syst Biol Reprod Med. 2019 Feb;65(1):54-60. doi: 10.1080/19396368.2018.1554012. Epub 2018 Dec 10.
3
Efficacy and safety of Ding-Kun-Dan for female infertility patients with predicted poor ovarian response undergoing in vitro fertilization/intracytoplasmic sperm injection: study protocol for a randomized controlled trial.定坤丹用于体外受精/卵胞浆内单精子注射治疗中预测卵巢反应不良的女性不孕症患者的疗效与安全性：一项随机对照试验的研究方案
Trials. 2018 Feb 20;19(1):124. doi: 10.1186/s13063-018-2511-0.
4
Gonadotropin versus Follicle-Stimulating Hormone for Ovarian Response in Patients Undergoing in vitro Fertilization: A Retrospective Cohort Comparison.促性腺激素与促卵泡生成素对体外受精患者卵巢反应的影响：一项回顾性队列比较研究
Curr Ther Res Clin Exp. 2019 Dec 2;92:100572. doi: 10.1016/j.curtheres.2019.100572. eCollection 2020.
5
Live birth rates using conventional in vitro fertilization compared to intracytoplasmic sperm injection in Bologna poor responders with a single oocyte retrieved.在博洛尼亚单卵母细胞获取的低反应者中，使用常规体外受精与卵胞浆内单精子注射的活产率比较。
J Assist Reprod Genet. 2015 May;32(5):691-7. doi: 10.1007/s10815-015-0459-5. Epub 2015 Mar 11.
6
Reproductive function in men conceived with in vitro fertilization and intracytoplasmic sperm injection.体外受精和胞浆内单精子注射受孕男性的生殖功能。
Fertil Steril. 2022 Apr;117(4):727-737. doi: 10.1016/j.fertnstert.2021.12.026. Epub 2022 Feb 2.
7
The association between in vitro fertilization and intracytoplasmic sperm injection treatment and the risk of congenital heart defects.体外受精-胞浆内单精子注射治疗与先天性心脏病风险的关系。
J Matern Fetal Neonatal Med. 2022 Dec;35(25):7471-7485. doi: 10.1080/14767058.2021.1949705. Epub 2021 Jul 7.
8
Factors impacting couples' decision-making between vasectomy reversal versus sperm retrieval/in vitro fertilization/intracytoplasmic sperm injection.影响夫妇选择输精管复通术与精子提取/体外受精/卵胞浆内单精子注射的因素。
Andrology. 2018 Jul;6(4):556-558. doi: 10.1111/andr.12491. Epub 2018 Apr 2.
9
In vitro fertilization and multiple pregnancies: an evidence-based analysis.体外受精与多胎妊娠：一项基于证据的分析。
Ont Health Technol Assess Ser. 2006;6(18):1-63. Epub 2006 Oct 1.
10
Assisted reproductive techniques.辅助生殖技术
Methods Mol Biol. 2014;1154:171-231. doi: 10.1007/978-1-4939-0659-8_8.
引用本文的文献
1
Intra-ovarian injection of autologous menstrual blood-derived-mesenchymal stromal cells: a safe and promising method to improve pregnancy rate in poor ovarian responders.卵巢内注射自体月经血来源的间充质基质细胞：一种提高卵巢反应不良患者妊娠率的安全且有前景的方法。
Stem Cell Res Ther. 2025 Apr 12;16(1):171. doi: 10.1186/s13287-025-04278-6.
2
Metabolomics-Driven Insights into Biomarkers for Poor Ovarian Response: A Narrative Review.代谢组学驱动的卵巢反应不良生物标志物研究见解：一项叙述性综述
Biomedicines. 2025 Jan 16;13(1):214. doi: 10.3390/biomedicines13010214.
本文引用的文献
1
Type and dose of gonadotropins in poor ovarian responders: does it matter?卵巢低反应者中促性腺激素的类型和剂量：这有关系吗？
Ther Adv Reprod Health. 2021 Jun 27;15:26334941211024203. doi: 10.1177/26334941211024203. eCollection 2021 Jan-Dec.
2
Double or dual stimulation in poor ovarian responders: where do we stand?卵巢低反应者的双重或双刺激：我们目前的状况如何？
Ther Adv Reprod Health. 2021 Jun 30;15:26334941211024172. doi: 10.1177/26334941211024172. eCollection 2021 Jan-Dec.
3
Mitochondrial enrichment in infertile patients: a review of different mitochondrial replacement therapies.不育患者的线粒体富集：不同线粒体替代疗法综述
Ther Adv Reprod Health. 2021 Jun 28;15:26334941211023544. doi: 10.1177/26334941211023544. eCollection 2021 Jan-Dec.
4
Human growth hormone use in poor ovarian response - caution and opportunities.生长激素在卵巢低反应中的应用——注意事项与机遇
Ther Adv Reprod Health. 2021 Mar 19;15:2633494121999420. doi: 10.1177/2633494121999420. eCollection 2021 Jan-Dec.
5
Randomised controlled trial on the effect of clomiphene citrate and gonadotropin dose on ovarian response markers and IVF outcomes in poor responders.枸橼酸氯米酚和促性腺激素剂量对卵巢反应标志物及低反应患者 IVF 结局影响的随机对照试验
Hum Reprod. 2021 Mar 18;36(4):987-997. doi: 10.1093/humrep/deaa336.
6
ESHRE guideline: ovarian stimulation for IVF/ICSI.ESHRE指南：体外受精/卵胞浆内单精子注射的卵巢刺激
Hum Reprod Open. 2020 May 1;2020(2):hoaa009. doi: 10.1093/hropen/hoaa009. eCollection 2020.
7
Adjuvant treatment strategies in ovarian stimulation for poor responders undergoing IVF: a systematic review and network meta-analysis.辅助治疗策略在 IVF 中对卵巢刺激反应不良者的应用：系统评价和网络荟萃分析。
Hum Reprod Update. 2020 Feb 28;26(2):247-263. doi: 10.1093/humupd/dmz046.
8
Modified natural cycle IVF versus conventional stimulation in advanced-age Bologna poor responders.改良自然周期 IVF 与传统刺激在高龄博洛尼亚低反应者中的应用。
Reprod Biomed Online. 2019 Oct;39(4):698-703. doi: 10.1016/j.rbmo.2019.05.009. Epub 2019 May 16.
9
Human growth hormone for poor responders: a randomized placebo-controlled trial provides no evidence for improved live birth rate.对于反应不良者使用人生长激素：一项随机安慰剂对照试验并未提供改善活产率的证据。
Reprod Biomed Online. 2019 Jun;38(6):908-915. doi: 10.1016/j.rbmo.2019.02.003. Epub 2019 Feb 27.
10
A Novel Predictive Model to Estimate the Number of Mature Oocytes Required for Obtaining at Least One Euploid Blastocyst for Transfer in Couples Undergoing Fertilization/Intracytoplasmic Sperm Injection: The ART Calculator.一种新型预测模型，用于估计在接受体外受精/卵胞浆内单精子注射的夫妇中获得至少一个可用于移植的整倍体囊胚所需的成熟卵母细胞数量：辅助生殖技术计算器。
Front Endocrinol (Lausanne). 2019 Feb 28;10:99. doi: 10.3389/fendo.2019.00099. eCollection 2019.
Zotero 插件